Health care regulation agency Frier Levitt has analyzed FDA enforcement steps in opposition to “analysis only” peptide sellers. Their conclusion: the FDA considers a product’s classification dependant on its supposed use, not its disclaimers. When Internet websites include dosage guides, reconstitution Recommendations, or website link to comm